GlassScriptPhysician profile
Mitchell J Durante
NPI 1861837783
$1,655.03
in general payments reported to CMS, 2019-2025
19 companies · $19.83 in 2025
The $19.83 reported for 2025 was less than what a typical Hospitalist provider received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $334 · 2020: $86.78 · 2021: $397 · 2022: $118 · 2023: $331 · 2024: $369 · 2025: $19.83.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $719.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $719.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $225.61 | 2023 | Synchromedii, Micra, Linq II |
| Janssen Pharmaceuticals, INC | $169.87 | 2019-2023 | Xarelto |
| Merck Sharp & Dohme LLC | $162.59 | 2019-2024 | Dificid, Verquvo, Zerbaxa |
| Pfizer INC. | $156.94 | 2019-2024 | |
| Abbvie INC. | $139.59 | 2024 | |
| Abiomed | $138.84 | 2021 | |
| Gilead Sciences, INC. | $112.81 | 2021-2025 | Veklury |
| Cumberland Pharmaceuticals, INC. | $79.98 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $78.42 | 2021-2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $63.01 | 2019-2020 | |
| Kestra Medical Technology Services, INC. | $61.55 | 2023-2024 | Assure Wcd |
| Amgen INC. | $60.26 | 2019-2020 | |
| Edwards Lifesciences Corporation | $46.16 | 2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Novartis Pharmaceuticals Corporation | $44.76 | 2020-2021 | |
| E.R. Squibb & Sons, L.L.C. | $38.10 | 2020-2024 | Eliquis |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $23.69 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.52 | 2019 | |
| Mallinckrodt Hospital Products INC. | $17.02 | 2024 | Terlivaz |
| Otsuka America Pharmaceutical, INC. | $16.31 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mitchell Durante listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.